12 August

Megeys - instruction , application reviews

Contents:

1. Pharmacological action

2. Pharmacokinetics

3. release form Megeysa

4. Indications

5. Megeysa Instructions:how to use

6. Side effects

7. Overdose Megeysom

8. Contraindications

9. shelf life and storage conditions Megeysa

Megeys is an anticancer drug.

Pharmacological action

Megestrol - the main active ingredient of this tool, which is a synthetic hormone progestogen, have a direct impact on the process of pregnancy.

According Megeysa instructions, the drug has anti-tumor properties.Thus Megeys injected directly into the uterus.Furthermore, the tool effectively in the treatment of diseases such as anorexia or cachexia.

In accordance with the review of Megeyse, the use of this tool helps to increase body weight, as well as an increase in the number of adipose tissue.

Pharmacokinetics

degree of inactivation of the drug in the gastrointestinal tract and liver directly related to the concentrations in the plasma, which in turn can affect

the intestinal microflora, the mobility of the intestinal tract, the simultaneous use of antibiotics, diet, weightbody, as well as the functional state of the liver.

On metabolites account for only five to eight percent of the introduced into the body dose of megestrol acetate.

kidneys and bowels are the main ways of removing the tool from the patient's body.Thus kidney average output of about 66% of the drug while using the intestine - about 20% of the administered dose.Part

dose which after injection can not be detected in the stool or urine can be released through the respiratory system and accumulate in fatty tissue.

release form Megeysa

The drug is available in the form of tablets Megeys.

Indications

Megeysa The instructions stated that this tool is widely used for the purpose of palliative care, which is a therapy aimed at temporary improvement in the patient's condition, endometrial cancer or breast cancer.

In addition, according to numerous reviews about Megeyse, the drug is also effective against anorexia or abnormal weight reduction.This tool is also used in the treatment of acquired immunodeficiency syndrome, and malignant tumors.

Megeysa Guide: how to use

in accordance with the instructions Megeysa, the drug is intended for oral administration.The course of treatment an average of two months - this is the duration of therapy with Megeysa recommended to achieve the expected outcomes.When

breast cancer drug is administered usually at a dosage of 160 mg per day.In cancer, endometrial daily dosage of 80-320 mg.In the treatment of anorexia or weight reduction, this means prescribed at a dose of 300-400 mg daily.

elderly patients is appointed, as a rule, the standard treatment regimen.

should be noted that the drug can be administered only under the supervision of a specialist, who already have experience with patients undergoing chemotherapy.

According to reviews of Megeyse, during therapy is recommended to take birth control pills.

addition instructions Megeysa also notes that in the course of treatment with the use of this tool can be carried out chemotherapy, radiation therapy, and surgery for cancer.

Side effects

Application Megeysa can cause rapid weight gain.This effect is usually observed in patients suffering from breast cancer and endometrial cancer.Thus, this agent in some cases to provoke an improvement of appetite.

According to reviews of Megeyse, the drug can also cause the development of pulmonary embolism, thromboembolism, thrombophlebitis, bleeding from the uterus, edema, nausea, vomiting, shortness of breath, high blood pressure, heart failure, hot flashes, hyperglycemia, mood changes, balding, short progressiontumors, diarrhea, skin rash, latergii.

also use this tool can provoke the development of glucose intolerance and diabetes, as well as the occurrence of adrenal insufficiency.

These symptoms of adrenal gland malfunction may develop in patients immediately after the cessation of treatment.

In some cases, in order to eliminate unwanted side effects of prescribed steroids in shock doses.

Megeysom

Overdose During clinical trials Megeys used at a dosage of 1600 mg per day for six months or more.Thus as a result of the experiments it was found not to have any toxic effects of the drug on the body.

In case of overdose of data means, as a rule, being symptomatic therapy.

Contraindications

Megeys contraindicated administered to children under the age of 18 years and for women during pregnancy and lactation.In addition, the tool should not be taken if the patient has an individual hypersensitivity to the main active ingredients of the drug, as well as the presence of individual intolerance of one or more components of the preparation.

With extreme caution is recommended to take this means to patients in the past, those suffering thrombophlebitis.

shelf life and storage conditions Megeysa

drug should be stored in a dry place inaccessible to children at temperature not exceeding 25 ° C.Subject to the required conditions of the tool shelf life will be three years.

preparation is available in pharmacies only by prescription.

Attention!

Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.

Latest Blog Post

Neuleptil - instruction , application reviews
August 12, 2017

Contents: 1. Instruction Neuleptilu: indications for use 2. reviews Neuleptile: side effects 3. Contraindications 4. Terms an...

The drug Nervohel - instruction , application reviews
August 12, 2017

Contents: 1. Indications 2. Instruction Nervohelyu 3. reviews Nervohele 4. Side effects and contraindications Nervohel ...

Neoton - instruction , application reviews
August 12, 2017

Contents: 1. Pharmacological action 2. Indications for use drugs Neoton 3. Neoton Dosing instructions for 4. Contraindication...